Clinical trial
A Study to Treat Patients Whose Chronic Angina Symptoms Are Not Relieved by…
NCT00215696 · GenVec, Industry · Completed
Key facts
| NCT number | NCT00215696 |
|---|---|
| Title | A Study to Treat Patients Whose Chronic Angina Symptoms Are Not Relieved by Medication and Have an Area of the Heart That Cannot be Treated by Standard Therapies |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of BIOBYPASS® (ADGVVEGF121.10NH) Delivered by NOGA™-GUIDED/MYOSTAR™ Catheter in "No Option" Patients With Class II-IV Stable Angina |
| Lead sponsor | GenVec, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Moderate to Severe Angina Pectoris |
| Intervention type | Genetic |
| Interventions | BioBypass® |
| Enrollment | 129 |
| Start date | Apr 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | May 13, 2011 |
| Countries | Denmark, Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: